Original language | English |
---|---|
Pages (from-to) | 32-33 |
Number of pages | 2 |
Journal | Psychiatry and Clinical Neurosciences |
Volume | 76 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2022 Jan |
ASJC Scopus subject areas
- Neuroscience(all)
- Neurology
- Clinical Neurology
- Psychiatry and Mental health
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Increasing trend in the prevalence of alcohol-sensitive individuals with alcohol use disorder over the past 40 years. / Ueno, Fumihiko; Uchida, Hiroyuki; Kimura, Mitsuru et al.
In: Psychiatry and Clinical Neurosciences, Vol. 76, No. 1, 01.2022, p. 32-33.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Increasing trend in the prevalence of alcohol-sensitive individuals with alcohol use disorder over the past 40 years
AU - Ueno, Fumihiko
AU - Uchida, Hiroyuki
AU - Kimura, Mitsuru
AU - Yokoyama, Akira
AU - Yonemoto, Tomoko
AU - Itoh, Mitsuru
AU - Yumoto, Yosuke
AU - Nakayama, Hideki
AU - Matsushita, Sachio
N1 - Funding Information: FU has received fellowship grants from Discovery Fund, Nakatani Foundation, and the Canadian Institutes of Health Research (CIHR); and consultant fee from VeraSci, and Uchiyama Underwriting within the past 3 years. HU has received grants from Eisai, Otsuka Pharmaceutical, Dainippon‐Sumitomo Pharma, Mochida Pharmaceutical, Meiji‐Seika Pharmaceutical, and Novartis; speaker's honoraria from Otsuka Pharmaceutical, Eli Lilly, Shionogi, Pfizer, Yoshitomi Yakuhin, Dainippon‐Sumitomo Pharma, Meiji‐Seika Pharma, MSD, and Janssen Pharmaceutical; and advisory panel payments from Dainippon‐Sumitomo Pharma within the past 3 years. YY has received grants from Ministry of Health, Labor and Welfare, and Japan Agency for Medical Research and Development; and personal fees from Otsuka Pharmaceutical Company Limited, and Nippon Shinyaku Company Limited within the past 3 years. HN has received grants from Japan Agency for Medical Research and Development, and Japan Health and Labor Sciences within the past 3 years. SM has received grants from Asahi Quality & Innovations, Ltd.; personal fees from EA Pharma, Ono Yakuhin, Otsuka Pharmaceutical, and Yoshitomi Yakuhin within the past 3 years. MK, AY, TY, and MI have nothing to disclose. Funding Information: This study was supported by a research grant from Suntory Holdings Limited. The funding source had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.
PY - 2022/1
Y1 - 2022/1
UR - http://www.scopus.com/inward/record.url?scp=85120626881&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85120626881&partnerID=8YFLogxK
U2 - 10.1111/pcn.13307
DO - 10.1111/pcn.13307
M3 - Letter
C2 - 34708490
AN - SCOPUS:85120626881
SN - 1323-1316
VL - 76
SP - 32
EP - 33
JO - Psychiatry and Clinical Neurosciences
JF - Psychiatry and Clinical Neurosciences
IS - 1
ER -